Clinical Trial Update: To Investigate Efficacy, Pharmacodynamics, and Safety of BC 007 in Participants With Long COVID [Phase 2]

View source ↗

Summary

Phase 2 clinical trial investigating efficacy, pharmacodynamics, and safety of BC 007 in participants with Long COVID has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Long Covid

Drugs mentioned

• BC 007 (BC-007)

Snippet

Sponsor: Berlin Cures GmbH | Conditions: Long Covid | Phase 2 | Status: COMPLETED